Centre Hospitalier Universitaire Universite Catholique de Louvain Site Godinne

Yvoir B-5530

0 studies enrolling now · 5 studies all time

What they study most

B-Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma; Non-Hodgkin Lymphoma, Metastatic Non-Squamous Non-Small Cell Lung Cancer, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed B-Cell Non-Hodgkin Lymphoma, Relapsed Hodgkin Lymphoma, Small Lymphocytic Lymphoma

Studies at this site

• A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7) — Running, not enrolling
• A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation — Running, not enrolling
• A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL — Running, not enrolling
• Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer — Completed
• Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma — Completed